Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney Sells 30,000 Shares

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 30,000 shares of the company’s stock in a transaction that occurred on Wednesday, January 15th. The stock was sold at an average price of $13.61, for a total transaction of $408,300.00. Following the completion of the transaction, the president now owns 1,606,097 shares of the company’s stock, valued at approximately $21,858,980.17. The trade was a 1.83 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Dawn Christine Maroney also recently made the following trade(s):

• On Friday, November 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $11.35, for a total value of $340,500.00.

Alignment Healthcare Trading Up 0.2 %

ALHC stock opened at $14.58 on Monday. Alignment Healthcare, Inc. has a twelve month low of $4.46 and a twelve month high of $14.79. The stock has a market capitalization of $2.79 billion, a price-to-earnings ratio of -18.94 and a beta of 1.45. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82. The firm’s fifty day simple moving average is $11.94 and its two-hundred day simple moving average is $10.80.

Alignment Healthcare (NASDAQ:ALHC) last posted its quarterly earnings data on Tuesday, October 29th. The company reported ($0.14) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.14). Alignment Healthcare had a negative net margin of 5.84% and a negative return on equity of 108.69%. The company had revenue of $692.43 million for the quarter, compared to analyst estimates of $662.11 million. During the same period in the prior year, the company posted ($0.19) EPS. The firm’s revenue for the quarter was up 51.6% on a year-over-year basis. As a group, analysts anticipate that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Analysts Set New Price Targets

ALHC has been the subject of a number of research analyst reports. Barclays increased their price objective on shares of Alignment Healthcare from $7.00 to $8.00 and gave the company an “underweight” rating in a report on Wednesday, October 30th. KeyCorp began coverage on shares of Alignment Healthcare in a report on Friday, October 11th. They issued a “sector weight” rating on the stock. Stifel Nicolaus raised their price objective on Alignment Healthcare from $14.00 to $16.00 and gave the company a “buy” rating in a research report on Tuesday, January 14th. UBS Group boosted their target price on Alignment Healthcare from $9.00 to $12.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 30th. Finally, Stephens restated an “overweight” rating and set a $17.00 price target on shares of Alignment Healthcare in a report on Thursday, January 2nd. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, seven have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $11.88.

Hedge Funds Weigh In On Alignment Healthcare

A number of large investors have recently bought and sold shares of the business. nVerses Capital LLC bought a new stake in shares of Alignment Healthcare during the third quarter worth $95,000. Ballentine Partners LLC bought a new stake in Alignment Healthcare during the 4th quarter valued at about $121,000. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in Alignment Healthcare in the 3rd quarter valued at about $131,000. Creative Planning increased its position in shares of Alignment Healthcare by 20.0% during the third quarter. Creative Planning now owns 12,442 shares of the company’s stock worth $147,000 after acquiring an additional 2,072 shares during the period. Finally, Intech Investment Management LLC bought a new stake in shares of Alignment Healthcare during the third quarter valued at approximately $315,000. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.